TF and glioblastoma: This in vitro evaluation highlights the unique therapeutic potential of Tf@pSiNPs against GBM cell migration, and the therapeutic anti-migratory effect of Tf@pSiNPs, which could be further optimised by incorporating a more effective CSC-targeting strategy.